Reiko Yamada

Dr. Reiko Yamada

orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 May 2019 in Clinical Journal of Gastroenterology
Verified
Journal Article
Open access
PDF file
YNYoshifumi Nakamura
Yoshifumi Nakamura
RYReiko Yamada
Reiko Yamada
MKMaki Kaneko
Maki Kaneko
HNHiroaki Naota
Hiroaki Naota
YFYu Fujimura
Yu Fujimura
KTKyosuke Tanaka
Kyosuke Tanaka
Isolated pancreatic metastasis from malignant melanoma is rare. Pancreatic metastasis is difficult to diagnose in patients with unknown primary malignant melanoma. Endoscopic ultrasound-guided fine-needle aspiration plays an important role in confirming the diagnosis. A 67-year-old woman was referred to our institution because of a mass in her pancreas. Computed tomography and magnetic resonance imaging revealed a 35-mm mass localized on the pancreatic tail, with low attenuation, surrounded by a high-attenuation rim. Endoscopic ultrasonography revealed a hypoechoic mass with central anechoic areas. Endoscopic ultrasound-guided fine-needle aspiration of the mass was performed, and the pathological diagnosis was malignant melanoma. Intense fluorodeoxyglucose uptake was observed in the pancreatic tail on positron emission tomography–computed tomography. No other malignant melanoma was found. Distal pancreatectomy was performed. Six months postoperatively, positron emission tomography–computed tomography revealed high uptake in the left nasal cavity, and biopsy revealed the mass to be a malignant melanoma, indicating that the primary site of the malignant melanoma was the left nasal cavity and that the pancreatic mass and peritoneal lesion were metastases. The patient had survived > 2 years after the distal pancreatectomy. Pancreatic resection of isolated pancreatic metastasis can possibly prolong survival; however, metastatic melanoma usually has poor prognosis.

1 December 2013 in Endoscopy
Verified
Journal Article
Closed access
HIHiroyuki Inoue
Hiroyuki Inoue
MTMasahiko Tameda
Masahiko Tameda
RYReiko Yamada
Reiko Yamada
STShunske Tano
Shunske Tano
MKMasaki Kasturahara
Masaki Kasturahara
YTYoshiyuki Takei
Yoshiyuki Takei
A 65-year-old man was referred to our hospital with obstructive jaundice. Laboratory tests showed elevated levels of alkaline phosphatase (1932 U/L; normal range 35 – 104 U/L), γ-glutamyltransferase (1030 U/L; normal value < 39 U/L), and bilirubin (3.6 mg/dL; normal value < 1.2 mg/dL). The tumor antigen CA 19-9 was also elevated (226.4 U/L; normal value < 37 U/L). Abdominal computed tomography showed a well-demarcated mass in the head of the pancreas ([Fig. 1]). This was 4 cm in diameter with a heterogeneous enhancing pattern. Endoscopic retrograde cholangiopancreatography showed a smooth stricture of the distal common bile duct ([Fig. 2]), and a plastic biliary stent (8.5 Fr, 7 cm) was inserted into the bile duct. Although endoscopic ultrasound-guided fine-needle aspiration (EUS-FNA) was carried out ([Fig. 3]), definitive diagnoses could not be made because the samples from EUS-FNA contained only normal-looking pancreatic tissue. Pancreaticoduodenectomy was performed. Microscopically, the specimen showed a well-demarcated solid mass ([Fig. 4]), and the tumor was composed of non-neoplastic acinar and ductal cells embedded in a hypocellular fibrous stroma ([Fig. 5]). Immunohistochemically, the spindle-shaped stromal cells were positive for CD34 and negative for c-kit. The ductal components were positive for S-100. The histological diagnosis was pancreatic hamartoma. There was no evidence of recurrence up to 3 years after surgery. Pancreatic hamartoma is a non-neoplastic, mass-forming lesion of the pancreas and is extremely rare. The pathogenesis of these tumors remains unknown. The major histopathological features of pancreatic hamartoma are mature acini and small to medium-sized ducts showing a distorted architecture with various amounts of fibrous stroma. Immunohistochemically, the ductal components are positive for S-100 and the spindle-shaped stromal cells express CD34 and/or c-kit [1] [2]. Weight loss and abdominal pain are the most common symptoms characterizing pancreatic hamartoma. To the best of our knowledge, our report describes the first case of pancreatic hamartoma manifesting initially as obstructive jaundice. Endoscopy_UCTN_Code_CCL_1AF_2AZ_3AB

9 October 2020 in Clinical Journal of Gastroenterology
Verified
Journal Article
Open access
PDF file
AHAi Hamano
Ai Hamano
RYReiko Yamada
Reiko Yamada
KKKazunari Kurata
Kazunari Kurata
JTJunya Tsuboi
Junya Tsuboi
HIHiroyuki Inoue
Hiroyuki Inoue
YTYoshiyuki Takei
Yoshiyuki Takei
A 71-year-old man on prednisolone for immunoglobulin (Ig) G4-related renal disease showed increased carbohydrate antigen (CA) 19–9 level; abdominal enhanced computed tomography (CT) showed a lesion in the left lateral segment and dilatation of the peripheral biliary duct. He was referred to our hospital for detailed examination for suspected intrahepatic cholangiocarcinoma. CT and magnetic resonance imaging findings were similar to those for intrahepatic cholangiocarcinoma. However, endoscopic retrograde cholangiopancreatography showed a smooth narrowing of the bile duct which suggested inflammatory disease. Liver biopsy was performed; IgG4-related hepatic inflammatory pseudotumor (IPT) was diagnosed. IgG4-related hepatic IPTs are rare diseases that develop in association with the development of sclerosing cholangitis. Most of these lesions develop in the hepatic hilum and the imaging findings of these tumors are similar to those of hilar cholangiocarcinomas. Thus, hepatic IPTs are difficult to differentiate from malignancy; in some cases, surgical resection has been considered for establishing the diagnosis. In the present case, we could diagnose hepatic IPT on the basis of liver biopsy, which is the recommended approach in cases of suspected hepatic IPT.

25 May 2023 in Pancreatology
Verified
Journal Article
Closed access
TKToshifumi Kin
Toshifumi Kin
YSYasuhiro Shimizu
Yasuhiro Shimizu
Susumu HijiokaSusumu Hijioka
Susumu Hijioka
KHKazuo WINDOW Hara Hara
Kazuo WINDOW Hara Hara
AKAkio Katanuma
Akio Katanuma
YTYoshifumi Takeyama
Yoshifumi Takeyama

1 January 2015 in Internal Medicine
Verified
Journal Article
Closed access
TKTakashi Kitade
Takashi Kitade
NHNoriyuki Horiki
Noriyuki Horiki
MKMasaki Katsurahara
Masaki Katsurahara
TTToshiaki Totoki
Toshiaki Totoki
THTetsuro Harada
Tetsuro Harada
YTYoshiyuki Takei
Yoshiyuki Takei
A 66-year-old Japanese man consulted our institution due to paroxysmal and repetitive bouts of fever and abdominal pain that had persisted for more than one week. Capsule and double-balloon endoscopy (DBE) showed petal-shaped mucosal redness with white hemming in the jejunum and ileum, and histopathology of the biopsy specimens revealed villous atrophy and cryptitis with extensive severe neutrophil infiltration. A genetic examination disclosed compound heterozygous MEFV mutations (E84K, P369S), and familial Mediterranean fever was diagnosed. Treatment with colchicine and infliximab was very effective in inducing the complete disappearance of symptoms and normalization of the endoscopic findings. To the best of our knowledge, this is the first report to describe the findings of small intestinal endoscopic images obtained using capsule and DBE.

11 June 2023 in Biomedicines
Verified
Journal Article
Open access
PDF file
RYReiko Yamada
Reiko Yamada
JTJunya Tsuboi
Junya Tsuboi
YMYumi Murashima
Yumi Murashima
TTTakamitsu Tanaka
Takamitsu Tanaka
KNKenji Nose
Kenji Nose
HNHayato Nakagawa
Hayato Nakagawa
Pancreatic cancer is one of the most lethal human malignancies, in part because it is often diagnosed at late stages when surgery and systemic therapies are either unfeasible or ineffective. Therefore, diagnosing pancreatic cancer in earlier stages is important for effective treatment. However, because the signs and symptoms may be nonspecific and not apparent until the disease is at a late stage, the timely diagnoses of pancreatic cancer can be difficult to achieve. Recent studies have shown that selective screening and increased usage of biomarkers could improve the early diagnosis of pancreatic cancer. In this review, we discuss recent advancements in the early detection of pancreatic ductal carcinoma and precancerous lesions. These include innovations in imaging modalities, the diagnostic utility of various biomarkers, biopsy techniques, and population-based surveillance approaches. Additionally, we discuss how machine learning methods are being applied to develop integrated methods of identifying individuals at high risk of developing pancreatic disease. In the future, the overall survival of pancreatic cancer patients could be improved by the development and adoption of these new methods and techniques.